Regentis Biomaterials Ltd (NASDAQ:RGNT) | WebDisclosure

Basculer en Français

10965	Companies
240075	Keywords
168812	Articles
129158	Press releases

Headlines Articles Press releases Regentis Biomaterials Ltd

Home
Companies
Regentis Biomaterials Ltd

BRIEF

published on 09/11/2026 at 15:05, 25 minutes ago

Regentis Biomaterials Updates on Financial and Clinical Progress

European Expansion Clinical Progress Financial Results 2026 Regentis Biomaterials GelrinC® Trial
BRIEF

published on 09/11/2026 at 15:05, 25 minutes ago

Mises à jour de Regentis Biomaterials sur les progrès financiers et cliniques

Expansion Européenne Résultats Financiers 2026 Régents Biomaterials Essai GelrinC® Progrès Cliniques
PRESS RELEASE

published on 09/11/2026 at 15:00, 30 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Regentis Biomaterials reports progress on GelrinC® pivotal trial with 43 patients treated and U.S. enrollment completion expected by end of 2026, strengthens balance sheet, and expands European readiness for commercialization

Financial Results Commercialization Clinical Trial Regentis Biomaterials GelrinC®

Accesswire

Published on 09/11/2026 at 15:00, 30 minutes ago

Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 1 hour ago

AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 1 hour 32 minutes ago

BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 2 hours 30 minutes ago

Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 11 hours 30 minutes ago

Torq Announces Debt Settlement and Corporate Update

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 15:22, 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Published on 09/11/2026 at 15:17, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc
Published on 09/11/2026 at 14:35, 54 minutes ago

EQS-Adhoc: Österreichische Post AG: AUSTRIAN POST REACHES AGREEMENT WITH THE REPUBLIC OF AUSTRIA TO PAY COMPENSATION FOR SOCIAL CONTRIBUTIONS RELATING TO CIVIL SERVANTS FOR THE YEARS 1996 TO 2008
Published on 09/11/2026 at 14:25, 1 hour 4 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 09/11/2026 at 14:21, 1 hour 8 minutes ago

Amundi Physical Metals plc: Final Terms

Les Echos

Published on 09/11/2026 at 07:00, 8 hours 30 minutes ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 8 hours 30 minutes ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 8 hours 30 minutes ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 8 hours 30 minutes ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 20 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE